{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:55:05Z","timestamp":1771656905509,"version":"3.50.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2024,4,27]]},"DOI":"10.2217\/imt-2023-0225","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T13:29:47Z","timestamp":1711459787000},"page":"501-511","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Certolizumab pegol in the treatment of axial spondyloarthritis"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9925-6644","authenticated-orcid":false,"given":"Elizabeth","family":"Anderson","sequence":"first","affiliation":[{"name":"Oregon Health & Sciences University, Division of Rheumatology, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Secia","family":"Beier","sequence":"additional","affiliation":[{"name":"Oregon Health & Sciences University, Department of Pharmacy Services, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julianna","family":"Desmarais","sequence":"additional","affiliation":[{"name":"Oregon Health & Sciences University, Division of Rheumatology, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01491.x"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001575"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211734"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041129"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41042"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223296"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.188"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205322"},{"key":"e_1_3_6_12_1","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. Cimzia (Certolizumab Pegol) Injection (125160) Approval letter April 22 2008. Retrieved August 25 2023: www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/125160s000_Approv.pdf"},{"key":"e_1_3_6_13_1","unstructured":"Cimzia [Prescribing Information]. UCB Revised: April 2020."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0239-z"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2016.1205581"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38973"},{"issue":"1","key":"e_1_3_6_18_1","doi-asserted-by":"crossref","first-page":"e000659","DOI":"10.1136\/rmdopen-2018-000659","article-title":"Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a Phase III study","volume":"4","author":"Van Der Heijde D","year":"2018","unstructured":"Van Der Heijde D, Braun J, Rudwaleit M, Purcaru O, Kavanaugh AF. Improvements in workplace and household productivity with certolizumab pegol treatment in axial spondyloarthritis: results to week 96 of a Phase III study. RMD Open 4(1), e000659 (2018).","journal-title":"RMD Open"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22594"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212377"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000430"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab841"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40866"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02650-4"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11469"},{"issue":"1","key":"e_1_3_6_26_1","doi-asserted-by":"crossref","first-page":"e002138","DOI":"10.1136\/rmdopen-2021-002138","article-title":"Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active nonradiographic axial spondyloarthritis: 3-year results from the Phase III C-axSpAnd study","volume":"8","author":"Van Der Heijde D","year":"2022","unstructured":"Van Der Heijde D, Gensler LS, Maksymowych WP et al. Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active nonradiographic axial spondyloarthritis: 3-year results from the Phase III C-axSpAnd study. RMD Open 8(1), e002138 (2022).","journal-title":"RMD Open"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216839"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa181"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.33.1.162"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-022-00522-0"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0645-1"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13820"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01257-6"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04771-3"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22848"},{"issue":"1","key":"e_1_3_6_36_1","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001161","article-title":"The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW","volume":"6","author":"Van Der Horst-Bruinsma I","year":"2020","unstructured":"Van Der Horst-Bruinsma I, Van Bentum R, Verbraak FD et al. The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW. RMD Open 6(1) (2020).","journal-title":"RMD Open"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211003803"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2016.03.014"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211384"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41191"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex457"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00442-x"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109256"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-222260"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0336-2"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203660"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000942"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5003"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11259"},{"issue":"5","key":"e_1_3_6_50_1","first-page":"752","article-title":"Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today","volume":"35","author":"Bartalesi F","year":"2017","unstructured":"Bartalesi F, Scir\u00e8 CA, Requena-M\u00e9ndez A et al. Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today. Clin. Exp. Rheumatol. 35(5), 752\u2013765 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.941919"},{"issue":"91","key":"e_1_3_6_52_1","first-page":"56","article-title":"Tuberculosis risk in patients treated with non-anti-tumor necrosis Factor-a (TNF-a) targeted biologics and recently licensed TNF-a inhibitors: data from clinical trials and national registries","volume":"41","author":"Cantini F","year":"2014","unstructured":"Cantini F, Niccoli L, Goletti D. Tuberculosis risk in patients treated with non-anti-tumor necrosis Factor-a (TNF-a) targeted biologics and recently licensed TNF-a inhibitors: data from clinical trials and national registries. J. Rheumatol. 41(Suppl. 91), 56\u201364 (2014).","journal-title":"J. Rheumatol."},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05248-4"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5341"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223499"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00098-4"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3115-7"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209270"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1238458"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.334"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.149419"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2021.20230"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6928"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25045"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221244"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130945"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811829"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2023-0225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:58:06Z","timestamp":1727218686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2023-0225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4,27]]}},"alternative-id":["10.2217\/imt-2023-0225"],"URL":"https:\/\/doi.org\/10.2217\/imt-2023-0225","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}